<?xml version="1.0" encoding="UTF-8"?>
<ref id="B33-ijerph-17-04951">
 <label>33.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cousien</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Leclerc</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Morissette</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bruneau</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Roy</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Tran</surname>
    <given-names>V.C.</given-names>
   </name>
   <name>
    <surname>Cox</surname>
    <given-names>J.</given-names>
   </name>
  </person-group>
  <article-title>The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montreal, Canada: A modelling study</article-title>
  <source>BMC Infect. Dis.</source>
  <year>2017</year>
  <volume>17</volume>
  <elocation-id>162</elocation-id>
  <pub-id pub-id-type="doi">10.1186/s12879-017-2256-5</pub-id>
  <pub-id pub-id-type="pmid">28222681</pub-id>
 </element-citation>
</ref>
